![Yvette Zimmerman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yvette Zimmerman
Chief Executive Officer at Pantarhei Bioscience BV
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Herjan Coelingh Bennink | M | - |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands.
Pantarhei Bioscience BV
![]() Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | 37 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert R. Buck | M | 76 |
Kendle International LLC
![]() Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | 13 years |
Timothy M. Mooney | M | 76 |
Kendle International LLC
![]() Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | 6 years |
Angelien G. Z. Kemna | M | 66 |
Maastricht University
| 6 years |
Anthony L. Forcellini | M | - |
Kendle International LLC
![]() Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | 15 years |
Hein F. J. Ploegmakers | M | - |
Maastricht University
| 6 years |
Feng Chen | M | 71 |
Maastricht University
| 2 years |
Jörg Spiekerkötter | M | 66 |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | 1 years |
Gary M. Wedig | M | - |
Kendle International LLC
![]() Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | 16 years |
Armand Lumens | M | - |
Maastricht University
| 2 years |
Nikolai R. D. Pronk | M | 50 |
Maastricht University
| 5 years |
Eric M. van der Aa | M | - |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | 5 years |
Monique Visser | M | - |
Kendle International LLC
![]() Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | 5 years |
Frans van den Berg | M | - |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | - |
Yvonne Schlaeppi | F | 64 |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | 1 years |
Roger Dassen | M | 59 |
Maastricht University
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 11 | 68.75% |
United States | 5 | 31.25% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yvette Zimmerman
- Personal Network